List of works - Andrew Siderowf

18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study

scientific article published on 5 October 2017

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

scientific article

Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology

scientific article published on January 2009

Apolipoprotein E-ε4 increases the risk for dementia in the ‘pure’ synucleopathies

scholarly article by Debby Tsuang et al published July 2012 in Alzheimer's and Dementia

Association between cognition and function in patients with Parkinson disease with and without dementia

scientific article

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

scientific article

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

scientific article

Biomarkers for atypical Parkinsonism: Some progress, but much work remains

scientific article published in March 2018

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Breaking the news: A survey of ALS patients and their caregivers

Bridging the credibility gap in cost effectiveness analysis.

scientific article published on 11 December 2013

Building an integrated neurodegenerative disease database at an academic health center ⬇️

scientific article published on July 1, 2011

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders

scientific article published on 21 February 2018

Can a Screening Questionnaire Accurately Identify Mild Parkinsonian Signs ⬇️

scientific article published on August 29, 2012

Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: Getting to the heart of the matter ⬇️

scientific article published on October 30, 2010

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

scientific article

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

scientific article

Clinical trials with rasagiline: evidence for short-term and long-term effects

scientific article published on May 2006

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

scientific article

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

scientific article published in PLoS ONE

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

scientific article published on 21 August 2015

Cognitive impairment and PD patients' capacity to consent to research

scientific article

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease

scientific article published on 05 December 2007

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

scientific article published on 8 June 2017

Daytime sleepiness is associated with falls in Parkinson's disease

scientific article published on January 2013

Delayed Parkinson’s Disease Diagnosis among African-Americans: The Role of Reporting of Disability ⬇️

scientific article published on April 20, 2011

Design of comprehensive Alzheimer's disease centers to address unmet national needs

scientific article

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

scientific article

Development of quality of care indicators for Parkinson's disease

scientific article published on February 2004

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease

scientific article published on 2 October 2004

Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)

scientific article

Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder ⬇️

scientific article published on September 29, 2011

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

scientific article

Early Retirement and Income Loss in Patients with Early and Advanced Parkinsonʼs Disease

scientific article published on November 1, 2011

Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria.

scientific article published on 8 January 2016

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

scientific article published on 5 August 2017

Everyday Action Impairment in Parkinson's Disease Dementia ⬇️

scientific article published on May 24, 2012

F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients

scientific article published in June 2008

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study

scientific article published in September 2010

Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival

scientific article

Genetic influences on cognitive decline in Parkinson's disease ⬇️

scientific article published on February 16, 2012

Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest

scientific article published on 8 April 2011

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations

scientific article published on 06 July 2011

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

scientific article

Impairment of script comprehension in Lewy body spectrum disorders

scientific article published on 06 April 2013

Impairments of speech fluency in Lewy body spectrum disorder ⬇️

scientific article published on November 17, 2011

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings

Local institutional review board (IRB) review of a multicenter trial: local costs without local context

scientific article

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease

scientific article published in June 2006

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort

scientific article published on 23 March 2018

Longitudinal study of normal cognition in Parkinson disease

scientific article published on 11 September 2015

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease

scientific article published on 8 March 2013

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

scientific article published on 02 July 2008

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease

scientific article

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

scientific article

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study

scientific article

Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease

scientific article published on 26 February 2016

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy

scientific article

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

scientific article

Observations on a 2-Step Approach to Screening for Parkinson Disease-Reply

scientific article published on 6 November 2017

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease ⬇️

scientific article published on October 15, 2010

Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy

scientific article published on August 2008

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders

scientific article

Parkinson's at risk syndrome: can Parkinson's disease be predicted?

scientific article published in January 2010

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

scientific article

Piloting the NPF data-driven quality improvement initiative

scientific article

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

scientific article published on 29 March 2016

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

scientific article

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

scientific article

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

scientific article

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline ⬇️

scientific article published on January 1, 2013

Preclinical diagnosis of Parkinson's disease: are we there yet?

scientific article published on July 2006

Premotor Parkinson's disease: clinical features and detection strategies

scientific article published on January 2009

Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

scientific article

Premotor Parkinson's disease: concepts and definitions

scientific article published in April 2012

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference

scientific article published on 23 September 2014

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging

scientific article published on 7 January 2017

Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale ⬇️

scientific article published on December 1, 2011

Racial differences in the diagnosis of Parkinson's disease

scientific article

Rasagiline improves quality of life in patients with early Parkinson's disease

scientific article published in May 2006

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

scientific article published on 13 December 2017

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition

scientific article published on 11 January 2017

Screening for impulse control symptoms in patients with de novo Parkinson disease ⬇️

scientific article published on January 8, 2013

Screening questionnaires for parkinsonism: A systematic review ⬇️

scientific article published on September 17, 2011

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease

scientific article

Sentence processing in Lewy body spectrum disorder: The role of working memory ⬇️

scientific article published on January 2, 2012

TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia

scholarly article by Thomas F. Tropea et al published 14 May 2019 in Annals of Neurology

Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial

scientific article

The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease

scientific article

The organization of narrative discourse in Lewy body spectrum disorder ⬇️

scientific article published on October 1, 2011

Treatment disparities in Parkinson's disease

scientific article

Update on Parkinson disease

scientific article

Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study

scientific article published on 14 September 2017

List of works by Andrew Siderowf

18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology

Apolipoprotein E-ε4 increases the risk for dementia in the ‘pure’ synucleopathies

Association between cognition and function in patients with Parkinson disease with and without dementia

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

Biomarkers for atypical Parkinsonism: Some progress, but much work remains

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Breaking the news: A survey of ALS patients and their caregivers

Bridging the credibility gap in cost effectiveness analysis.

Building an integrated neurodegenerative disease database at an academic health center ⬇️

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders

Can a Screening Questionnaire Accurately Identify Mild Parkinsonian Signs ⬇️

Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: Getting to the heart of the matter ⬇️

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

Clinical trials with rasagiline: evidence for short-term and long-term effects

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

Cognitive impairment and PD patients' capacity to consent to research

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

Daytime sleepiness is associated with falls in Parkinson's disease

Delayed Parkinson’s Disease Diagnosis among African-Americans: The Role of Reporting of Disability ⬇️

Design of comprehensive Alzheimer's disease centers to address unmet national needs

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

Development of quality of care indicators for Parkinson's disease

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease

Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)

Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder ⬇️

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

Early Retirement and Income Loss in Patients with Early and Advanced Parkinsonʼs Disease

Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria.

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

Everyday Action Impairment in Parkinson's Disease Dementia ⬇️

F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study

Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival

Genetic influences on cognitive decline in Parkinson's disease ⬇️

Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

Impairment of script comprehension in Lewy body spectrum disorders

Impairments of speech fluency in Lewy body spectrum disorder ⬇️

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings

Local institutional review board (IRB) review of a multicenter trial: local costs without local context

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort

Longitudinal study of normal cognition in Parkinson disease

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study

Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

Observations on a 2-Step Approach to Screening for Parkinson Disease-Reply

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease ⬇️

Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders

Parkinson's at risk syndrome: can Parkinson's disease be predicted?

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

Piloting the NPF data-driven quality improvement initiative

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline ⬇️

Preclinical diagnosis of Parkinson's disease: are we there yet?

Premotor Parkinson's disease: clinical features and detection strategies

Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

Premotor Parkinson's disease: concepts and definitions

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging

Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale ⬇️

Racial differences in the diagnosis of Parkinson's disease